Regulatory comments

IATP submitted this comment to the Federal Register on U.S. Federal Organic Agriculture Standards and Nanotechnology: The National Organic Standards Board Materials Committee Guidance Document—Engineered Nanomaterials in Organic Production, Processing and Packaging.

KAW official comments on FDA Draft Guidance 209. KAW asks that the FDA stop further delays and make public what meaningful steps it intends to take to address the problem of the inappropriate use of antimicrobials in food-producing animals, including the use of antimicrobials for routine disease prevention.

KAW comments on the Food and Drug Administration’s (FDA) Advance Notice of Proposed Rulemaking (ANPR) regarding potential changes to its current regulation relating to veterinary feed directive (VFD) drugs, 75 Fed. Reg., 15387-88 (March 29, 2010).

IATP comment on the revision of the European Commission Market Abuse Directive (MAD) to extend the authority of the MAD to cover Over the Counter (OTC) trades and trades on unregulated venues. Given the volume, value and volatility of OTC trades ($300 trillion in notional value for U.S.

Keep Antibiotics Working Statement for the Record, House of Representatives, Health Subcommittee to the Energy and Commerce Committee Hearing on the Public Health Risk from the Use of Antibiotics in Food-Producing Animals.

The Des Moines Register published a 7-part series on Africa by reporter Philip Brasher who traveled to Kenya and South Africa to obtain information for the series. It focused on corn (maize in Africa) and the role of biotechnology, both the political and yield aspects, in providing food for sub-Sahara Africa.